Home
/
CANNAPHARMARX, INC.
/
Financials
/
Quarterly
CANNAPHARMARX, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CANNAPHARMARX, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$656.6K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$231.6K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$335.3K
May 16, 2025
Q3
2025
Sep 30, 2024
$312.2K
Nov 14, 2025
Q2
2025
Jun 30, 2024
$0
Aug 14, 2025
Q1
2025
Mar 31, 2024
$25.8K
May 16, 2025
Q3
2024
Sep 30, 2023
$0
Nov 14, 2024
Q2
2023
Jun 30, 2023
$0
Oct 13, 2023
Q1
2024
Mar 31, 2023
$0
Jun 25, 2024
Q3
2023
Sep 30, 2022
$0
Nov 17, 2023
Q2
2023
Jun 30, 2022
$0
Oct 13, 2023
Q1
2023
Mar 31, 2022
$0
Sep 22, 2023
Q3
2022
Sep 30, 2021
$0
Nov 21, 2022
Q2
2022
Jun 30, 2021
$0
Aug 22, 2022
Q1
2022
Mar 31, 2021
$0
May 23, 2022
Q3
2021
Sep 30, 2020
$0
Nov 15, 2021
Q2
2021
Jun 30, 2020
$0
Aug 16, 2021
Q1
2021
Mar 31, 2020
$0
May 17, 2021
Q3
2020
Sep 30, 2019
$0
Nov 12, 2020
Q2
2020
Jun 30, 2019
$0
Aug 19, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.48M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.41M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($690.6K)
May 16, 2025
Q3
2025
Dec 31, 2024
($3.74M)
Nov 14, 2025
Q1
2025
Dec 31, 2024
$1.81M
May 16, 2025
Q2
2025
Dec 31, 2024
($3.55M)
Aug 14, 2025
Q3
2025
Sep 30, 2024
$188.4K
Nov 14, 2025
Q2
2025
Jun 30, 2024
$5.36M
Aug 14, 2025
Q3
2024
Jun 30, 2024
$5.36M
Nov 14, 2024
Q1
2025
Mar 31, 2024
($11.72M)
May 16, 2025
Q3
2024
Mar 31, 2024
($11.72M)
Nov 14, 2024
Q1
2024
Dec 31, 2023
$5.10M
Jun 25, 2024
Q3
2024
Sep 30, 2023
($564.4K)
Nov 14, 2024
Q2
2023
Jun 30, 2023
($1.88M)
Oct 13, 2023
Q3
2024
Jun 30, 2023
($1.88M)
Nov 14, 2024
Q1
2024
Mar 31, 2023
($1.41M)
Jun 25, 2024
Q2
2023
Mar 31, 2023
($1.41M)
Oct 13, 2023
Q3
2024
Mar 31, 2023
($1.41M)
Nov 14, 2024
Q3
2023
Sep 30, 2022
($1.31M)
Nov 17, 2023
Q2
2023
Jun 30, 2022
($1.51M)
Oct 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($935.6K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($841.0K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($667.7K)
May 16, 2025
Q3
2025
Sep 30, 2024
($516.0K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($517.8K)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($790.2K)
May 16, 2025
Q3
2024
Sep 30, 2023
($667.5K)
Nov 14, 2024
Q2
2023
Jun 30, 2023
($892.9K)
Oct 13, 2023
Q1
2024
Mar 31, 2023
($720.3K)
Jun 25, 2024
Q3
2023
Sep 30, 2022
($588.5K)
Nov 17, 2023
Q2
2023
Jun 30, 2022
($704.1K)
Oct 13, 2023
Q1
2023
Mar 31, 2022
($715.6K)
Sep 22, 2023
Q3
2022
Sep 30, 2021
($771.2K)
Nov 21, 2022
Q2
2022
Jun 30, 2021
($796.1K)
Aug 22, 2022
Q1
2022
Mar 31, 2021
($721.3K)
May 23, 2022
Q3
2021
Sep 30, 2020
($1.31M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($787.5K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($2.57M)
May 17, 2021
Q3
2020
Sep 30, 2019
($6.36M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($688.9K)
Aug 19, 2020